Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation

International Journal of Molecular Medicine

Volumn 27, Issue 1, 2011, Pages 3-14

  Yamaguchi, Masayoshi ^a   Weitzmann, M Neale ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Menaquinone 7; NF B; Osteoblast; Osteoclast; Osteoporosis; Vitamin K

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FARNOQUINONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CARBOXYLATION; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; BONE RESORPTION; CELL DIFFERENTIATION; FEMALE; I-KAPPA B PROTEINS; MICE; NF-KAPPA B; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND; SIGNAL TRANSDUCTION; SMAD PROTEINS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN K 2; VITAMINS;

EID: 78651069683     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2010.562     Document Type: Article

References (50)

1. Boyce BF, Xing L, Franzoso G and Siebenlist U: Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone 25: 137-139, 1999.
2. Hall TJ, Schaeublin M, Jeker H, Fuller K and Chambers TJ: The role of reactive oxygen intermediates in osteoclastic bone resorption. Biochem Biophys Res Commun 207: 280-287, 1995.
3. Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R and Novack DV: RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest 118: 2088-2097, 2008.
4. Vaira S, Johnson T, Hirbe AC, et al: RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci USA 105: 3897-3902, 2008.
5. Liu J, Wang S, Zhang P, Said-Al-Naief N, Michalek SM and Feng X: Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis. J Biol Chem 284: 2512-12523, 2009.
6. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A and Bravo R: Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3: 1285-1289, 1997.
7. Strait K, Li Y, Dillehay DL and Weitzmann MN: Suppression of NF-κB activation blocks osteoclastic bone resorption during estrogen deficiency. Int J Mol Med 21: 521-525, 2008.
8. Feng R, Anderson G, Xiao G, et al: SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth. Blood 109: 2130-2138, 2007.
9. Dai S, Hirayama T, Abbas S and Abu-Amer Y: The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 279: 37219-37222, 2004.
10. Lu X, Farmer P, Rubin J and Nanes MS: Integration of the NFkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription. J Cell Biochem 92: 833-848, 2004.
11. Gilbert LC, Rubin J and Nanes MS: The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab 288: E1011-E1018, 2005.
12. Nanes MS: Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 321: 1-15, 2003.
13. Wahl EC, Aronson J, Liu L, et al: Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res 25: 114-123, 2010.
14. Zhang F, Qiu T, Wu X, et al: Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res 24: 1224-1233, 2009.
15. Janssens K, ten Dijke P, Janssens S and van Hul W: Transforming growth factor-beta1 to the bone. Endocr Rev 26: 743-774, 2005.
16. Tang Y, Wu X, Lei W, et al: TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15: 757-765, 2009.
17. Li Y, Li A, Strait K, Zhang H, Nanes MS and Weitzmann MN: Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation, through NF-kappaB. J Bone Miner Res 22: 646-655, 2007.
18. Eliseev RA, Schwarz EM, Zuscik MJ, O'Keefe RJ, Drissi H and Rosier RN: Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFkappaB. Exp Cell Res 312: 40-50, 2006.
19. Guo R, Yamashita M, Zhang Q, et al: Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem 283: 23084-23092, 2008.
20. Chang J, Wang Z, Tang E, et al: Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med 15: 682-689, 2009.
21. Yamaguchi M and Weitzmann MN: The estrogen 17β-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-κB activity. Int J Mol Med 23: 297-301, 2009.
22. Yamaguchi M and Ma ZJ: Inhibitory effect of menaquinone-7 (vitamin K2) on osteoclast-like cell formation and osteoclastic bone resorption in rat bone tissues in vitro. Mol Cell Biochem 228: 39-47, 2001.
23. Yamaguchi M, Sugimoto E and Hachiya S: Stimulatory effect of menaquinone-7 (vitamin K2) on osteoblastic bone formation in vitro. Mol Cell Biochem 223: 131-137, 2001.
24. Kamao M, Suhara Y, Tsugawa N, et al: Vitamin K content of foods and dietary vitamin K intake in Japanese young women. J Nutr Sci Vitaminol (Tokyo) 53: 464-470, 2007.
25. Cheung AM, Tile L, Lee Y, et al: Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 5: e196, 2008.
26. Shea MK and Booth SL: Update on the role of vitamin K in skeletal health. Nutr Rev 66: 549-557, 2008.
27. Hauschka PV, Lian JB and Gallop PM: Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci USA 72: 3925-3929, 1975.
28. Price PA: Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function. Vitam Horm 42: 65-108, 1985.
29. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ and Delmas PD: Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9: 1591-1595, 1994.
30. Szulc P, Chapuy MC, Meunier PJ and Delmas PD: Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91: 1769-1774, 1993.
31. Binkley N, Harke J, Krueger D, et al: Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J Bone Miner Res 24: 983-991, 2009.
32. Sakagami H, Satoh K, Hakeda Y and Kumegawa M: Apoptosis-inducing activity of vitamin C and vitamin K. Cell Mol Biol (Noisy-le-grand) 46: 129-143, 2000.
33. Yamaguchi M and Weitzmann MN: The bone anabolic carotenoid β-cryptoxanthin enhances transforming growth factor-β1-induced SMAD activation in MC3T3 preosteoblasts. Int J Mol Med 24: 671-675, 2009.
34. Sugimoto E and Yamaguchi M: Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5: 515-520, 2000.
35. Abramoff MD, Magelhaes PJ and Ram SJ: Image Processing with ImageJ. Biophotonics Int 11: 36-42, 2004.
36. Atkins GJ, Welldon KJ, Wijenayaka AR, Bonewald LF and Findlay DM: Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by gamma-carboxylation- dependent and -independent mechanisms. Am J Physiol Cell Physiol 297: C1358-C1367, 2009.
37. Andrews NC and Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499, 1991.
38. Uchiyama S and Yamaguchi M: Anabolic effect of beta-cryptoxanthin in osteoblastic MC3T3-E1 cells is enhanced with 17beta-estradiol, genistein, or zinc sulfate in vitro: the unique effect with zinc on Runx2 and alpha1(I) collagen mRNA expressions. Mol Cell Biochem 307: 209-219, 2008.
39. Yamaguchi M, Uchiyama S and Tsukamoto Y: Stimulatory effect of menaquinone-7 on bone formation in elderly female rat femoral tissues in vitro: prevention of bone deterioration with aging. Int J Mol Med 10: 729-733, 2002.
40. Canalis E, Economides AN and Gazzerro E: Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24: 218-235, 2003.
41. Yamaguchi M, Taguchi H, Gao YH, Igarashi A and Tsukamoto Y: Effect of vitamin K2 (menaquinone-7) in fermented soybean (natto) on bone loss in ovariectomized rats. J Bone Miner Metab 17: 23-29, 1999.
42. Yamaguchi M, Uchiyama S and Tsukamoto Y: Inhibitory effect of menaquinone-7 (vitamin K2) on the bone-resorbing factors-induced bone resorption in elderly female rat femoral tissues in vitro. Mol Cell Biochem 245: 115-120, 2003.
43. Ozaki I, Zhang H, Mizuta T, et al: Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Clin Cancer Res 13: 2236-2245, 2007.
44. Hara K, Akiyama Y, Nakamura T, Murota S and Morita I: The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone 16: 179-184, 1995.
45. Morishita M, Nagashima M, Wauke K, Takahashi H and Takenouchi K: Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. J Rheumatol 35: 407-413, 2008.
46. Blonska M and Lin X: CARMA1-mediated NF-kappaB and JNK activation in lymphocytes. Immunol Rev 228: 199-211, 2009.
47. Colucci S, Brunetti G, Cantatore F, et al: Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol 212: 47-55, 2007.
48. Kawai T, Matsuyama T, Hosokawa Y, et al: B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 169: 987-998, 2006.
49. Okamoto H: Vitamin K and rheumatoid arthritis. IUBMB Life 60: 355-361, 2008.
50. Katsuyama H, Otsuki T, Tomita M, et al: Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int J Mol Med 15: 231-236, 2005.